Information Provided By: 
Fly News Breaks for April 26, 2016
ALGN
Apr 26, 2016 | 08:31 EDT
Roth Capital analyst Chris Lewis says his checks suggest that favorable underlying dental market trends remain, allowing Align Technology to continue its sales momentum. The analyst expects "solid" Q1 results paired with an inline Q2 guide that should support share appreciation. Lewis reiterates a Buy rating and $80 price target on the shares.
News For ALGN From the Last 2 Days
ALGN
Apr 18, 2024 | 07:23 EDT
Stifel raised the firm's price target on Align Technology to $400 from $350 and keeps a Buy rating on the shares. Respondents to the firm's survey point to "solid" 2024 year-over-year case volume growth and while Invisalign's share is expected to step down "modestly" year-over-year, new product feedback is upbeat, says the firm, which adds that it has "an upside bias to our 2024 revenue estimate."
